Risk Profile Improvements
- Going Concern (unchanged) — Substantial doubt about ability to continue as going concern persists due to insufficient cash and burn rate.
- Material Weakness (unchanged) — Material weakness in internal controls over financial reporting continues due to small accounting team size and staff turnover.
Valion Bio exits ClearUP device business, acquires CDMO assets; losses jump 56% to $8.9M
Filed March 30, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 21, 2025 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade VBIO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 4, 2026 6:23 PM